First Prospective Results Assessing the Clinical Utility and Clinical Benefit of Genomic Classifier Testing in Men Post-Prostatectomy

被引：0

作者：

Den, R. B. ^{[1
]}

Marascio, J. A. ^{[1
]}

Spratt, D. E. ^{[2
]}

Zhang, J. ^{[3
]}

Trabulsi, E. ^{[4
]}

Bloom, M. ^{[1
]}

Le, T. ^{[5
]}

Davicioni, E. ^{[6
]}

Gore, J. L. ^{[7
]}

Mann, M. ^{[1
]}

Mark, J. R. ^{[1
]}

Calvaresi, A. ^{[1
]}

Hurwitz, M. D. ^{[8
]}

Kelly, W. K. ^{[1
]}

Lallas, C. ^{[9
]}

Knudsen, K. E. ^{[10
]}

Gomella, L. G. ^{[11
]}

Dicker, A. P. ^{[1
]}

机构：

[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA

[2] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA

[3] GenomeDx, Vancouver, BC, Canada

[4] Jefferson Univ, Philadelphia, PA USA

[5] GenomeDx Biosci, San Diego, CA USA

[6] GenomeDx Inc, San Diego, CA USA

[7] Univ Washington, Seattle, WA 98195 USA

[8] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA

[9] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA

[10] Thomas Jefferson Univ, Dept Canc Biol, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA

[11] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期

关键词：

D O I：

10.1016/j.ijrobp.2019.06.1896

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2630

引用

页码：E274 / E274

页数：1

共 35 条

[1] Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy
Joseph Marascio
Daniel E. Spratt
Jingbin Zhang
Edouard J. Trabulsi
Tiffany Le
Worlanyo Sosu Sedzorme
Whitney H. Beeler
Elai Davicioni
Bashar Dabbas
Daniel W. Lin
John L. Gore
Matthew Bloom
Mark Mann
J. Ryan Mark
Anne Calvaresi
James L. Godwin
Peter McCue
Mark D. Hurwitz
W. Kevin Kelly
Costas D. Lallas
Karen E. Knudsen
Leonard G. Gomella
Adam P. Dicker
Robert B. Den
[J]. Prostate Cancer and Prostatic Diseases, 2020, 23 : 295 - 302
[2] Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy
Marascio, Joseph
Spratt, Daniel E.
Zhang, Jingbin
Trabulsi, Edouard J.
Le, Tiffany
Sedzorme, Worlanyo Sosu
Beeler, Whitney H.
Davicioni, Elai
Dabbas, Bashar
Lin, Daniel W.
Gore, John L.
Bloom, Matthew
Mann, Mark
Mark, J. Ryan
Calvaresi, Anne
Godwin, James L.
McCue, Peter
Hurwitz, Mark D.
Kelly, W. Kevin
Lallas, Costas D.
Knudsen, Karen E.
Gomella, Leonard G.
Dicker, Adam P.
Den, Robert B.
[J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2020, 23 (02) : 295 - 302
[3] Clinical Utility of a Genomic Classifier in Men Undergoing Radical Prostatectomy: The PRO-IMPACT Trial
Gore, John L.
du Plessis, Marguerite
Zhang, Jingbin
Dai, Darlene
Thompson, Darby J. S.
Karsh, Lawrence
Lane, Brian
Franks, Michael
Chen, David Y. T.
Bianco, Fernando J., Jr.
Brown, Gordon
Clark, William
Kibel, Adam S.
Kim, Hyung
Lowrance, William
Manoharan, Murugesan
Maroni, Paul
Perrapato, Scott
Sieber, Paul
Trabulsi, Edouard J.
Waterhouse, Robert
Spratt, Daniel E.
Davicioni, Elai
Lotan, Yair
Lin, Daniel W.
[J]. PRACTICAL RADIATION ONCOLOGY, 2020, 10 (02) : E82 - E90
[4] VALIDATION OF A GENOMIC CLASSIFIER THAT PREDICTS METASTATIC DISEASE PROGRESSION IN MEN WITH HIGH RISK PATHOLOGICAL FEATURES POST-PROSTATECTOMY
Karnes, R. Jeffrey
Ghadessi, Mercedeh
Bergstralh, Eric J.
Erho, Nicholas
Crisan, Anamaria
Davicioni, Elai
Buerki, Christine
Mitra, Anirban P.
Thompson, Darby J. S.
Carlson, Rachel
Haddad, Zaid
Zimmermann, Benedikt
Ballman, Karla V.
Kollmeyer, Thomas M.
Sierocinski, Thomas
Vergara, Ismael A.
Triche, Timothy J.
Black, Peter C.
Thompson, R. Houston
Jenkins, Robert B.
[J]. JOURNAL OF UROLOGY, 2013, 189 (04): : E872 - E873
[5] CLINICAL UTILITY OF A BRONCHIAL GENOMIC CLASSIFIER FOR LUNG CANCER DETECTION: RESULTS FROM A MULTICENTER PROSPECTIVE REGISTRY
Lee, Hans
Bhadra, Krish
Whitten, Patrick
Esterle, Mark
Bernstein, Michael
Dotson, Travis
Benzaquen, Sadia
Mazzone, Peter
Gordon, Joshiah
Hogarth, D.
Johnson, Marla
Huang, Jing
Griscom, Bailey
Lofaro, Lori
Kennedy, Giulia
Spira, Avrum
[J]. CHEST, 2018, 154 (04) : 597A - 599A
[6] DETERMINING THE IMPACT OF GENOMIC CLASSIFIER TESTING ON PATIENT-REPORTED QUALITY OF LIFE IN MEN AT HIGH-RISK OF POST-PROSTATECTOMY RECURRENCE: RESULTS FROM THE G-MINOR TRIAL
Singhal, Udit
Quarles, Jake
Spratt, Daniel
Okoth, Linda
Daignault-Newton, Stephanie
Dunn, Rodney
Feng, Felix
Johnson, Anna
Tosoian, Jeffrey
Lane, Brian
Linsell, Susan
Ghani, Khurshid
Montie, James
Hollenbeck, Brent
Mehra, Rohit
Davicioni, Elai
Todorovic, Tamara
Maatman, Thomas
Wojno, Kirk
Burks, Frank
Rodriguez, Paul
Kleer, Eduardo
Sarle, Richard
Miller, David
Cher, Michael
Morgan, Todd
[J]. JOURNAL OF UROLOGY, 2021, 206 : E1044 - E1044
[7] A genomic classifier to identify men with adverse pathology post radical prostatectomy who benefit from adjuvant radiation therapy.
Den, Robert Benjamin
Yousefi, Kasra
Trabulsi, Edouard John
Abdollah, Firas
Choeurng, Voleak
Feng, Felix Yi-Chung
Dicker, Adam
Lallas, Costas D.
Gomella, Leonard G.
Davicioni, Elai
Karnes, R. Jeffrey
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
[8] ASSESSING THE IMPACT OF A CLINICAL TRIAL PROTOCOL ON INTRA AND INTER-OBSERVER TARGET VOLUME CONTOURING FOR POST-PROSTATECTOMY RADIOTHERAPY
Logue, J.
Mitchell, D.
Perry, L.
Smith, S.
Elliott, T.
Cowan, R.
Livsey, J.
Wylie, J.
[J]. RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S313 - S313
[9] Clinical Utility of Chromosome Genomic Array Testing in Assessing TP53 Abnormalities in CLL
Fang, M.
Qu, X.
Soma, L.
McElhone, S.
Khajavian, S.
Lynch, R. C.
Smith, S.
Till, B.
Ujjani, C. S.
Gopal, A.
Shadman, M.
[J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1151 - 1151
[10] CORRELATION OF POST-PROSTATECTOMY DECIPHER GENOMIC CLASSIFICATION TO CLINICAL OUTCOMES IN PROSTATE CANCER OVER 8 YEAR FOLLOW-UP
Behers, Benjamin
Kortum, Spencer
Dolgetta, Genesis
Ghazli, Karim
King, Tonya
Bird, Victoria
Carey, Robert
[J]. JOURNAL OF UROLOGY, 2023, 209 : E746 - E747

← 1 2 3 4 →